The Indian pharma sector displayed mixed performance in early trading on January 13, 2026, as of approximately 9:50 AM IST. Broader market indices showed slight declines, with the S&P BSE Sensex at 83,674.75 (-0.24%) and Nifty 50 at 25,730.20 (-0.23%). The pharma sector mirrored this cautious trend, with many stocks experiencing minor dips.
Key Pharma Stock Movements (NSE Prices as of ~9:50 AM)
Here are selected notable performers from the provided data:
- Gainers:
- EMCURE PHARMACEUTICALS LTD. — 1,524.60 (+1.70%)
- HEALTHCARE GLOBAL ENTER. — 650.60 (+1.92%)
- NATCO PHARMA — 869.10 (+1.31%)
- ADVANCED ENZYME TECHNOLOGIES — 290.05 (+1.74%)
- SUDEEP PHARMA LTD. — 611.40 (+1.66%)
- Losers:
- GLENMARK PHARMA — 1,968.80 (-2.41%)
- CIPLA — 1,446.20 (-1.30%)
- DR. REDDYS LAB — 1,198.60 (-1.39%)
- IPCA LABS — 1,506.80 (-1.37%)
- JUBILANT INDUSTRIES — 1,633.50 (-4.46%) (notable sharp decline)
- Major Large-Cap Stocks:
- SUN PHARMA — 1,725.00 (-0.63%)
- DIVIS LABORATORIES — 6,431.00 (-0.84%)
- TORRENT PHARMA — 3,913.40 (-0.92%)
- ZYDUS LIFESCIENCES — 888.60 (-0.72%)
- LUPIN — 2,175.80 (-0.58%)
Other stocks like AJANTA PHARMA (2,711.50, -0.66%), ALKEM LABORATORIES (5,834.50, -0.55%), and AUROBINDO PHARMA (1,163.80, -0.78%) traded with modest declines.
This snapshot is based on real-time market data around 9:50 AM IST on January 13, 2026. Stock prices fluctuate rapidly; always verify with official exchange sources for the latest quotes. This is not investment advice.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.